Evidence map›Paper›PMID 42234947›Full record

ArticleJCO precision oncology2026

ErbB Receptor Feedback Inhibitor 1 Mutation in Biliary Tract Cancers: Turning Resistance Into Response.

Supriya Peshin, Fen Saj, Pashtoon M Kasi, Felicity David, Janio Szklaruk, Quentin Kimana, Shubham Pant, Sunyoung S Lee, Jennifer J Knox, Mitesh J Borad and 1 more

Abstract readMulticenter Study
In one paragraph

Article in JCO precision oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Supriya PeshinDepartment of Internal Medicine, Norton Community Hospital, Ballad Health, Norton, VA.ORCID 0000-0002-3895-9474
Fen SajDepartment of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.ORCID 0000-0003-0102-1789
Pashtoon M KasiDepartment of Oncology and Therapeutics Research, City of Hope Orange County, Irvine, CA.ORCID 0000-0002-5169-7085
Felicity DavidDepartment of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.
Janio SzklarukDepartment of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX.
Quentin KimanaDepartment of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.
Shubham PantDepartment of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.ORCID 0000-0001-9281-480X
Sunyoung S LeeDepartment of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.
Jennifer J KnoxDepartment of Medical Oncology and Hematology, Princess Margaret Cancer Center, Toronto, ON, Canada.ORCID 0000-0003-3474-6647
Mitesh J BoradDivision of Hematology & Oncology, Department of Medicine, Mayo Clinic, Scottsdale, AZ.ORCID 0000-0003-2700-2658
Milind JavleDepartment of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.ORCID 0000-0001-9158-0941

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purpose

methodsThis is a retrospective multicenter study of patients with BTC harboring

resultsFourteen BTC patients with

conclusion

Indexed as

Adaptor Proteins, Signal TransducingBiliary Tract NeoplasmsDrug Resistance, NeoplasmMutationTumor Suppressor ProteinsAdultAgedErbB ReceptorsFemaleHumansMaleMiddle AgedProtein Kinase InhibitorsRetrospective StudiesAdaptor Proteins, Signal TransducingEGFR protein, humanErbB ReceptorsERRFI1 protein, humanProtein Kinase InhibitorsTumor Suppressor Proteins

Identifiers

PMID42234947
PMCPMC13252979

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.